AI to transform all processes in drug development by 2026, predicts CPHI Report

In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs

Takeda emphasizes DEI to bring equal opportunities for all at the G20 Summit

The biopharmaceutical leader shared its expert perspective at the Equality Lounge at the G20 Summit

Apollo introduces India's first comprehensive Connected Care Services

This indigenously developed enhanced care technology is designed to continuously monitor and detect early signs of deterioration in a patient's condition

Global Digital Health Summit outlines roadmap for making India a global leader in digital health implementation

Sanofi announces changes to its Executive Committee

Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.

Vice President Jagdeep Dhankar delivers convocation address at the 48th AIIMS convocation

Rs. 64000 crores are being invested across the 750 districts of India, to create a more resilient healthcare system in the country

India's Medical Value sector projected to reach $ 13 billion by 2026: Dr Mandaviya

Need to harmonize traditional and modern medicine to combat alarming health problems

Cipla launches knowledge sharing platform ‘Ciplamed 2.0’

CiplaMed 2.0 leverages advanced analytics and automation

Exor to buy 15% shareholding in Philips

Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases

BioNTech appointing James Ryan as Chief Legal Officer

Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry